- You can view the full Biomarin Pharmaceutical Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
BioMarin (BMRN) stock was trading sharply higher this morning after Pfizer (PFE) beat out Sanofi (SNY) to purchase Medivation (MDVN).
Overall, this is still a good environment for stock picking.
BioMarin (BMRN) stock is trading lower after the market close after announcing a public offering of common stock.